American Diabetes Association Scientific Sessions
American Diabetes Association Scientific Sessions
June 15, 2016
3 min watch
Save

VIDEO: Measure glucose, not HbA1c

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW ORLEANS — In this video exclusive, Irl B. Hirsch, MD, professor of medicine at the University of Washington in Seattle, discusses implications of a study finding differences in the relationship between HbA1c and blood glucose in black and white populations.

The paradigm of diagnosing, treating and reimbursing based on HbA1c is limited by the assumption that the biomarker indicates the same glucose range in all patients. This can lead to undertreating a patient whose HbA1c is considered normal but whose glucose level is high, or overtreating in the opposite circumstance, according to Hirsch.

“HbA1c is a biomarker, but it’s far from perfect. ... We have the ability to measure glucose now and we need to do so,” Hirsch said.